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In the past 25 years, evidence has accumulated 
that people with schizophrenia are at increased risk 
to commit violent crimes and, to a lesser degree, 
non-violent crimes compared with the general 
population.1 A smaller amount of evidence suggests 
that patients with bipolar disorder are also at increased 
risk of committing violent oﬀ ences.2 Although both 
disorders are mainly treated with drugs that reduce risk 
of relapse, the eﬀ ect of antipsychotic medications and 
mood stabilisers on violence has been unclear. In view 
of the human suﬀ ering, stigma, and costs resulting 
from violence by people with these disorders, the 
identiﬁ cation of humane and eﬀ ective strategies to 
reduce such behaviours is an urgent unmet need.
In their study in The Lancet, Seena Fazel and 
colleagues3 used Swedish national registers to 
investigate whether prescriptions for antipsychotic 
drugs and mood stabilisers were associated with 
reductions in violent crime. During 2006–09, 
antipsychotics or mood stabilisers were prescribed 
to 40 937 men and 41 710 women in Sweden, of 
whom 2657 (6·5%) men and 604 (1·4%) women were 
convicted of a violent crime during the study period. 
Within-individual analyses were used to compare 
convictions for violent crime during periods when 
drugs were prescribed compared with periods when 
no prescriptions were dispensed. Violent crime was 
reduced by 45% in patients receiving antipsychotics 
(hazard ratio [HR] 0·55, 95% CI 0·47–0·64) and by 
24% in patients prescribed mood stabilisers (0·76, 
0·62–0·93). Depot medications (HR adjusted for 
concomitant oral drugs 0·60, 95% CI 0·39–0·92) and 
higher doses of antipsychotics were also associated 
with reductions in violent crime (p=0·019).
Similar reductions in the risk of violent crime were 
recorded in people with diagnoses of schizophrenia 
who were prescribed antipsychotic drugs, and in men, 
but not women, with diagnoses of bipolar disorder 
who were prescribed mood stabilisers. However, about 
60% of the patients prescribed antipsychotics or mood 
stabilisers did not have diagnoses of schizophrenia, 
bipolar disorder, or other psychoses. Despite this ﬁ nding, 
the reductions in violent crime during periods when 
medications were dispensed were detected in analyses 
that included all people prescribed these drugs. These 
results might represent the increased risk of violent 
behaviour in people with psychotic-like experiences who 
do not have psychotic disorders.4 This issue warrants 
further investigation.
The study was undertaken carefully, and sensitivity 
analyses suggest that the results are robust. No age 
eﬀ ects were detected in the association between 
antipsychotics and reductions in violent crime, while 
the association of mood stabilisers in older patients 
with bipolar disorder needs further investigation, as do 
diﬀ erences in associations in male and female patients. 
Similar reductions (22–29%) during periods when 
antipsychotics or mood stabilisers were prescribed were 
noted for any crime, drug-related crimes, less severe 
crimes, and suspected violent crimes. Thus, this study 
provides a basis for future investigations aimed at 
establishing the type of patient, phase of illness, and type 
and dose of medication that reduces physically aggres-
sive behaviour. However, many uncertainties remain 
regarding the treatment of aggression in schizophrenia5 
and bipolar disorder.
In their study, Fazel and colleagues used data from 
oﬃ  cial criminal records of violent crime. However, 
such criminal records capture only some physically 
aggressive behaviours, since family members and 
social and health-care workers—the usual victims—
often do not report such behaviours. Methods that ask 
patients and family and staﬀ  to report such behaviours 
have been shown to be valid.6 Importantly, in people 
with schizophrenia the correlates of aggressive 
behaviour and violent crime are similar.1 Fazel and 
colleagues note that randomised controlled trials 
studying the eﬀ ect of drug treatments on violence are 
rare because of low rates of violence. However, when 
physical aggression towards another is used as the 
dependent variable, this is not the case. For example, 
and consistent with previous evidence,1,6,7 two recent 
studies that followed patients for 1 year after a ﬁ rst 
episode of psychosis reported that 38%8 and 14%9 of 
the patients engaged in aggressive behaviour. These 
rates are suﬃ  ciently high to warrant examination of 
the characteristics of patients who hurt others, and 
of the eﬀ ects of drug treatment on such behaviours. 
These studies identiﬁ ed anger due to delusions8 and 
previous antisocial and aggressive behaviour9 as risk 
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factors for aggressive behaviour. Therefore, we should 
ask which antipsychotic drugs can reduce anger caused 
by delusions. And does the eﬀ ect of antipsychotics 
diﬀ er depending on the patient’s history of violence?
Violent oﬀ enders with schizophrenia do not 
constitute a homogeneous population.1,5,7 Rather, 
subtypes of oﬀ enders diﬀ er by age of onset of 
antisocial and aggressive behaviour. Those who 
commit the most oﬀ ences display a history of such 
behaviours from childhood and meet criteria for 
conduct disorder.1 Men with schizophrenia and 
previous conduct disorder have been shown to present 
with changes in grey matter in hypothalamic regions 
that underlie aggressive behaviour, as do men with 
previous conduct disorder and no schizophrenia.10 
In the CATIE trial, antipsychotic drugs were not 
associated with aggressive behaviour of patients with 
childhood conduct problems.5,7 In the study by Fazel 
and colleagues,3 a trend was noted showing larger 
reductions in violent crime in people with no previous 
history of violent crime than in those with previous 
convictions. This ﬁ nding is consistent with the 
notion that individuals with conduct disorder before 
schizophrenia onset represent a distinct phenotype 
who may respond diﬀ erently than other patients to 
antipsychotic drugs. Another subgroup of patients 
with schizophrenia begins to engage in aggressive 
behaviour as illness onsets. It has been suggested 
that substance misuse might promote this aggressive 
behaviour.1 Was the reduction in violent crime 
associated with antipsychotics and mood stabilisers 
observed by Fazel and colleagues due to an eﬀ ect on 
substance misuse?
During acute episodes of psychosis, when patients 
are often admitted to hospital against their will, many 
engage in aggressive behaviour towards others. In 
most cases, these behaviours disappear within days 
of administration of antipsychotic drugs. The main 
correlates of these behaviours are the severity of the 
positive psychotic symptoms such as hallucinations 
and delusions.11 By contrast, the primary correlates 
of aggressive behaviour in the community are male 
sex, history of antisocial and aggressive behaviour, 
and substance misuse.1,5 Fazel and colleagues studied 
patients living in the community and noted evidence 
of reductions of violence when antipsychotic drugs 
were prescribed. Does this eﬀ ect depend on the level 
of positive symptoms as previously suggested?12 
The phase of illness before the ﬁ rst acute episode 
also warrants investigation since many, if not most, 
patients with schizophrenia who will oﬀ end do so 
before their ﬁ rst contact with mental health-care 
services.13
Fazel and colleagues’ well executed study3 provides 
a basis for future clinical studies aiming to establish 
how antipsychotics and mood stabilisers can be used 
to reduce aggressive behaviour. The study illustrates 
again that de-identiﬁ ed data from national registers 
that were established for administrative reasons can be 
used by epidemiologists to identify potential strategies 
to reduce health-related social problems.
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